Telomir Pharmaceuticals, Inc. Common Stock (TELO)

Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $80.2M; returns 1 day -3.5%, 1 week -7.1%, 1 year -34.1%.

Telomir Pharmaceuticals Inc. (TELO) is a preclinical-stage biotechnology company focused on reversing biological aging and degenerative diseases. Their primary focus is the development of Telomir-1, an orally available small molecule metal ion regulator.

Groups TELO belongs to

• Biotechnology
• Preclinical Development
• Life Sciences
• Aging Population Needs
• Regenerative Medicine
• Drug Discovery
• Healthcare
• Oncology

TELO financial model: income statement, cash flow and balance sheet